Arrowhead Pharmaceuticals plans to offer $700 million in securities
Post Content
Business & Finance
Stay informed with expert takes on business strategy, investing, entrepreneurship, and global markets. CurioAtlas brings you articles that guide smarter decisions in finance and business growth.
Strategy’s stock is rising as investors get some much-needed good news
Strategy gets to stay in MSCI indexes for now — though the index provider says it will launch a more general review of whether investment-oriented companies can keep their spots.
Form 6K VisionSys AI Inc For: 6 January
Post Content
Form 6K NeuroSense Therapeutics Ltd. For: 6 January
Post Content
Form 6K Bright Minds Biosciences Inc For: 6 January
Post Content
Form 144 OneStream For: 6 January
Post Content
Form 144 EverCommerce Inc. For: 6 January
Post Content
Form 144 NETSKOPE For: 6 January
Post Content
Why U.S. oil refiners could be the big winners in Venezuela — even if its actual reserves disappoint
Refiners in the U.S. have the distinctive ability to handle the type of heavy crude Venezuela claims to have in abundance.
RBC Capital initiates Exelon stock coverage with Sector Perform rating
Post Content